Cargando…

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

OBJECTIVE: To quantify the effect on cervical disease at age 20 years of immunisation with bivalent human papillomavirus (HPV) vaccine at age 12-13 years. DESIGN: Retrospective population study, 1988-96. SETTING: National vaccination and cervical screening programmes in Scotland. PARTICIPANTS: 138 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmer, Tim, Wallace, Lynn, Pollock, Kevin G, Cuschieri, Kate, Robertson, Chris, Kavanagh, Kim, Cruickshank, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446188/ https://www.ncbi.nlm.nih.gov/pubmed/30944092 http://dx.doi.org/10.1136/bmj.l1161

Ejemplares similares

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
por: Pollock, K G J, et al.
Publicado: (2014)

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
por: Palmer, T J, et al.
Publicado: (2016)

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data
por: Palmer, T J, et al.
Publicado: (2016)

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
por: Kavanagh, Kimberley, et al.
Publicado: (2013)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis
por: Cuschieri, K, et al.
Publicado: (2016)

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
por: Cameron, Ross L., et al.
Publicado: (2016)

Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings
por: Conway, David I., et al.
Publicado: (2016)

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
por: Cuschieri, K, et al.
Publicado: (2010)

Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types
por: Tanton, Clare, et al.
Publicado: (2017)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes
por: Leshem, Eyal, et al.
Publicado: (2021)

HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland
por: O'Leary, M C, et al.
Publicado: (2011)

Monitoring HPV16/18 immunisation in England and elsewhere
por: Franceschi, S
Publicado: (2010)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

Development of a cross-cultural HPV community engagement model within Scotland
por: Carnegie, Elaine, et al.
Publicado: (2017)

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
por: Harper, Diane M., et al.
Publicado: (2011)

Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
por: Mesher, David, et al.
Publicado: (2016)

Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Hammad, Noha M., et al.
Publicado: (2021)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England()
por: Mesher, D., et al.
Publicado: (2013)

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples
por: Stevenson, Andrew, et al.
Publicado: (2018)

Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
por: Purriños-Hermida, M. Jesus, et al.
Publicado: (2018)

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females
por: Shi, Li-Wei, et al.
Publicado: (2023)

Neonatal immunity and immunisation in early age: lessons from veterinary medicine
por: Chappuis, G.
Publicado: (1998)

Ageing, sport and physical activity participation in Scotland
por: Davison, R. C. Richard, et al.
Publicado: (2023)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
por: Beecroft, Marikka, et al.
Publicado: (2022)

Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland
por: McCusker, Sarah M, et al.
Publicado: (2013)

Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data
por: McQuaid, Fiona, et al.
Publicado: (2022)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

HPV infection and pre-term birth: a data-linkage study using Scottish Health Data
por: Aldhous, Marian C., et al.
Publicado: (2019)

Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study
por: Seong, Jaehyun, et al.
Publicado: (2019)

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
por: Kreimer, Aimée R., et al.
Publicado: (2018)

Effects of Drinking-Water Filtration on Cryptosporidium Seroepidemiology, Scotland
por: Ramsay, Colin N., et al.
Publicado: (2014)

An urgent call to include men who have sex with men in the HPV immunisation programme in Kenya
por: Lorway, Robert R, et al.
Publicado: (2022)

Bivalent separation into univalents precedes age-related meiosis I errors in oocytes
por: Sakakibara, Yogo, et al.
Publicado: (2015)

Is Telomere Length a Biomarker for Aging: Cross-Sectional Evidence from the West of Scotland?
por: Der, Geoff, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jg8l25jgaskftblpdmpa1q4b7s